Choreo LLC’s Halozyme HALO Stock Holding History

Choreo LLC’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$314K	Buy	+4,011	New	+$273K	﹤0.01%	1273
2026 Q1	–	Sell	-3,075	Closed	-$208K	–	1657
2025 Q4	$208K	Sell	3,075 -448	-13%	-$30.1K	﹤0.01%	1432
2025 Q3	$258K	Buy	+3,523	New	+$234K	﹤0.01%	1317
2025 Q2	–	Sell	-12,643	Closed	-$807K	–	1556
2025 Q1	$807K	Sell	12,643 -36	-0.3%	-$2.09K	0.01%	633
2024 Q4	$608K	Sell	12,679 -2,293	-15%	-$118K	0.01%	801
2024 Q3	$848K	Buy	14,972 +2,236	+18%	+$128K	0.01%	638
2024 Q2	$663K	Buy	+12,736	New	+$559K	0.01%	683

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Choreo LLC's HALO Position: Q2 2026 in Review

Choreo LLC opened a new position in Halozyme (HALO) in Q2 2026: 4,011 shares worth $314K. The stake represents ﹤0.01% of the portfolio and ranks #1273 among its holdings. This is a return to the name: Choreo LLC previously reported a position in HALO as recently as Q4 2025.

Choreo LLC first reported a position in HALO in Q2 2024 and has held it in 7 quarters since. The position peaked at $848K in Q3 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Choreo LLC held 4,011 shares of Halozyme worth $314K as of Q2 2026.
Halozyme was a new Choreo LLC position in Q2 2026.
Halozyme made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1273 holding.
Choreo LLC first reported a position in Halozyme in Q2 2024 and has held it in 7 quarters since.
Choreo LLC's Halozyme position peaked at $848K in Q3 2024.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.